Oncotarget.net features press releases on the latest oncology research, as well as interviews from the distinguished network of authors who continue to publish their research with Oncotarget.

Tag: phase 1

Figure 1: Pre- and post-treatment scans confirmed partial responder. (From a phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.”)

Oncotarget

Riluzole and Sorafenib in Patients With Advanced Solid Tumors: A Phase I Trial

April 12, 2023

“Our phase I study determined the tolerable dose of this combination and investigated its biologic effects.” Listen to an audio version of this press release BUFFALO, NY- April 12, 2023… read more